ARCHIVES

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

This article is from The Cancer Letter archive.

Vol. 30 No. 04 | January 23, 2004

Download PDF Visit The Full Archive

Related Articles

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

NCCAM Awards To Establish Two Cancer Research Centers.

October 13, 2000

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975